Chimerix Inc (CMRX.OQ)
CMRX.OQ on NASDAQ Stock Exchange Global Market
22.04USD
1 Aug 2013
22.04USD
1 Aug 2013
Price Change (% chg)
$-0.70 (-3.08%)
$-0.70 (-3.08%)
Prev Close
$22.74
$22.74
Open
$23.03
$23.03
Day's High
$23.50
$23.50
Day's Low
$20.77
$20.77
Volume
24,640
24,640
Avg. Vol
19,039
19,039
52-wk High
$26.50
$26.50
52-wk Low
$15.11
$15.11
About
Chimerix, Inc. is a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need. Its lipid technology has given rise to two clinical-stage compounds, CMX001 and CMX157, which have... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $566.92 |
| Shares Outstanding (Mil.): | 25.72 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CMRX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 44.65 | 37.87 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | -2.30 | 18.70 |
| ROE: | -- | -2.12 | 19.53 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

